Skip to content

Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students

Pilot Observational Comparative Study Evaluating the Impact of the e-Bug Educational Programme on Parental Consent and HPV Vaccination Coverage During the National School-Based Vaccination Campaign in a Middle School in the Alpes-Maritimes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07266857
Enrollment
11000
Registered
2025-12-05
Start date
2025-05-01
Completion date
2025-12-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillomavirus Infection, Papillomavirus Vaccines, Vaccination Coveage

Brief summary

This study is a non-interventional observational pilot analysis assessing the possible impact of an educational programme (e-Bug) on parental consent and HPV vaccination uptake during the 2023-2024 and 2024-2025 national school-based HPV vaccination campaigns in France. The study focuses on one middle school in the Alpes-Maritimes department where teachers and the school nurse had been previously trained on HPV and used e-Bug educational resources in class as part of routine health education. No research-related intervention was conducted, and the educational programme was not introduced or modified for the purpose of the study. Only aggregated and anonymised vaccination data were used. These data were routinely collected by the Regional Health Agency (ARS PACA) as part of the national vaccination programme and transmitted for analysis. Aggregated data from the pilot school were compared with departmental-level outcomes to describe whether an upstream educational approach may be associated with improved parental acceptance and higher HPV vaccination coverage. This study aims to contribute to the understanding of educational determinants of vaccine uptake in a real-life school setting without involving any participant recruitment or individual data collection.

Interventions

OTHERConsent for HPV vaccination

Consent for HPV vaccination

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* No individual participants are enrolled. The study uses only aggregated, anonymised vaccination data routinely collected by ARS PACA

Exclusion criteria

* Not applicable. No individual-level inclusion or

Design outcomes

Primary

MeasureTime frameDescription
HPV vaccination uptake (1st and 2nd doses) in the pilot school compared with departmental dataFrom (start of 2023-2024 HPV vaccination campaign) to(end of 2024-2025)e-Bug educational programme

Secondary

MeasureTime frameDescription
Parental consent rate (acceptability)From (start of 2023-2024 HPV vaccination campaign) to(end of 2024-2025)Aggregated proportion of parents providing positive consent for HPV vaccination in the pilot school, compared with aggregated departmental consent rates collected by ARS PACA during the 2023-2024 and 2024-2025 school-based campaigns.
Response rate (return of vaccination authorisation forms)From (start of 2023-2024 HPV vaccination campaign) to(end of 2024-2025)Aggregated rate of returned parental authorisation forms (regardless of response: yes/no) in the pilot school compared with departmental response rates.

Countries

France

Contacts

Primary ContactLaure Hermet
hermet.l@chu-nice.fr0492039007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026